Technology
Health
Biotechnology

ARCA biopharma

$6.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-0.57%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell ARCA biopharma and other stocks, options, ETFs, and crypto commission-free!

About

ARCA biopharma, Inc. Common Stock, also called ARCA biopharma, is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. Read More The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.

Employees
15
Headquarters
Westminster, Colorado
Founded
1992
Market Cap
7.66M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
210.92K
High Today
$7.11
Low Today
$6.78
Open Price
$6.98
Volume
42.66K
52 Week High
$23.04
52 Week Low
$4.73

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Medical
Pharmaceutical
US
North America

News

NasdaqMay 9

Health Care Sector Update for 05/09/2019: ABIO, AGEN, ENDP, JNJ, PFE, ABT, MRK, AMGN

Top Health Care Stocks: JNJ: -0.48% PFE: -1.47% ABT: Flat MRK: -1.48% AMGN: -0.67% Health care majors were flat to lower pre-market Thursday. Early movers include: (+) ARCA biopharma ( ABIO ), which was advancing 9% after the company said Q1 net loss per share narrowed to $1.86 from a loss of $3.61 in the year-ago period and topped the CapIQ mean for a loss of $1.98. (+) Agenus ( AGEN ) was trading more than 5% higher after the company reported Q1 earnings of $0.12 per diluted share, up compared wi...

349
Markets InsiderMay 1

6 Top Gainers In Pharma Sector (ABIO, PRPO, VCYT...)

(RTTNews) - The following are some of today's top gainers in the pharma/biotech sector. 1. ARCA biopharma Inc. (ABIO) ARCA biopharma is a clinical-stage biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases. The Company's lead product candidate is Gencaro, which is in the development for the treatment of atrial fibrillation in certain patients who also have heart failure (HF). Gencaro is all set to advance into a phase III trial, dubbed PRECISION-AF, in the fourt...

1,114

Earnings

-$1.98
-$1.32
-$0.66
$0.00
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.